Results could provide insights into strategies for reducing anxiety symptoms in other contexts, outside of cannabis use.

The FDA plans to include aging and longevity among topics in the updated Focus Areas of Regulatory Science (FARS) report it plans to issue in federal FY 2027.

Internal benchmarks show that Ptarmigan-1 can run 5,000x faster than structure-based methods and screen over three billion compounds in a day.

Most screening readouts are snapshots. An endpoint measurement can obscure differences in association rate and dissociation ...

Methicillin-­resistant Staphylococcus aureus (MRSA) has rapidly risen to become one of the gravest threats to global health, with deaths from Staphylococcus aureus (S. aureus) having doubled worldwide ...

One of the strongest signals, albeit weaker than the original GWAS findings two decades ago, highlighted a novel regulatory ...

Mayo Clinic researchers have discovered that adults aged 50 years or younger with colorectal and breast cancers have distinct gut microbiome patterns compared with individuals diagnosed later in life.

AI-guided structural modeling and proteomics identified molecular glues that degrade VAV1, a potential target in blood cancers and autoimmune diseases.

Merck acquires global rights to SciBrunch Therapeutics’ SPR2015, a preclinical oral KRAS G12D inhibitor, in a deal worth up ...

Consortium members are expected to have access to the dataset by early 2027, and there are plans to add more complex antibody ...